Learning disabilities. Cerebral palsy. Mental retardation. A “silent pandemic” of these and other neurodevelopmental disorders is under way owing to industrial chemicals in the environment that impair brain development in fetuses and young children. That’s the conclusion of a data analysis by researchers at the Harvard School of Public Health (HSPH) and the Mount Sinai School of Medicine, who point to 201 chemicals – most of them common – known to inflict lasting neurological damage in humans. Information on possible neurotoxic effects exists, however, for only a small fraction of the thousands of chemicals in use around the world.
Scientists have muscled in on a genetic switch that allows mice to run longer and faster. Humans possess the same switch, so the discovery might open new paths to treating muscle-wasting diseases and building better bodies.
The plant with the world’s largest flower – typically a full meter across, with a bud the size of a basketball – evolved from a family of plants whose blossoms are nearly all tiny, botanists write this week in the journal Science. Their genetic analysis of rafflesia reveals that it is closely related to a family that includes poinsettias, castor oil plants, the tropical root crop cassava, and the trees that produce natural rubber.
A new map of human genetic diversity provides a powerful tool for understanding how each person is unique. Created by researchers at Harvard Medical School, Brigham and Women’s Hospital, and…
Even as studies have consistently found an association between moderate alcohol consumption and reduced heart attack risk in men, an important question has persisted: What if the men who drank…
Scientists at Dana-Farber Cancer Institute report they have found how the brain turns on a system designed to protect its nerve cells from toxic “free radicals,” a waste product of…
Many studies have shown the nutritional benefits of eating fish (finfish or shellfish). Fish is high in protein and omega-3 fatty acids. But concerns have been raised in recent years…
Each year, numerous postdoctoral and faculty fellowships/grants are available to the Harvard medical community by invitation only. These include the Burroughs Wellcome Career Award at the Scientific Interface, the Damon…
A designer drug significantly less toxic than thalidomide has shown impressive activity in prolonging survival of patients with advanced multiple myeloma, report researchers from Dana-Farber Cancer Institute. A multicenter Phase II study of lenalidomide, an altered version of thalidomide, found a response rate of 25 percent among patients with myeloma that had recurred despite multiple prior therapies. Especially important was that long-lasting responses averaging 28 months were seen. When another drug, dexamethasone, was added in patients who were not benefiting from lenalidomide alone, the response rate was improved in a third.
A treatment mainstay for prostate cancer puts men at increased risk for diabetes and cardiovascular disease, according to a large observational study published in the Sept. 20 Journal of Clinical Oncology. “Men with prostate cancer have high five-year survival rates, but they also have higher rates of noncancer mortality than healthy men,” says study author Nancy Keating, assistant professor of health care policy and of medicine at Harvard Medical School (HMS). “This study shows that a common hormonal treatment for prostate cancer may put men at significant risk for other serious diseases. Patients and physicians need to be aware of the elevated risk as they make treatment decisions.”
Findings from a study led by researchers at Dana-Farber Cancer Institute and Children’s Hospital Boston have rewritten science’s understanding of the process of skin tanning – an insight that has…
A treatment mainstay for prostate cancer puts men at increased risk for diabetes and cardiovascular disease, according to a large observational study published in the Sept. 20, 2006, Journal of…
A multi-institutional team of Harvard researchers may have advanced our understanding of physiological aging with a new study in which they greatly reduced the impact of aging on blood stem cells. A report on their findings appears in the latest edition of the journal Nature along with similar but independent findings from research teams at the universities of North Carolina and Michigan.
That intern working on you at the hospital may be so sleep-deprived his or her performance is no better than that of a drunk. That’s one conclusion of a national study by investigators at the Harvard Medical School.
Opening a whole new interface between nanotechnology and neuroscience, scientists at Harvard University have used slender silicon nanowires to detect, stimulate, and inhibit nerve signals along the axons and dendrites of live mammalian neurons.
More than 30 years after the end of the war in Vietnam, the effect of lingering stress on Americans who fought there continues to cause stress among researchers.
Heat waves, like the one that scorched the country in July, are more deadly for some people than for others. Poor blacks and diabetics fare the worst. As you might guess, extreme heat is also hard on the elderly. But as you might not guess, extreme cold has a greater impact.
Experts seeking to explain the amazing diversity of the tropical rain forest have typically done so in two ways, viewing forests as either “evolutionary cradles” that encourage the rapid development…
A study in the June 15, 2006, issue of The New England Journal of Medicine reveals that elevated levels of a molecule called RBP4 (retinol binding protein 4) can foretell…
Harvard Medical School researchers have discovered one way that a hardy disease-causing bacteria could be surviving in the lungs of chronically infected cystic fibrosis patients. “This work is important because…
After more than two years of intensive ethical and scientific review, Harvard Stem Cell Institute (HSCI) researchers at Harvard and Children’s Hospital Boston have been cleared to begin experiments using…
A novel approach to helping smokers kick the habit – a vaccine – will be tested at Massachusetts General Hospital (MGH). The nicotine vaccine NicVax is designed to keep nicotine…
Harvard Medical School announced May 23, 2006 that is has signed a multimillion-dollar license agreement with Merck & Co. Inc. to develop potential therapies for macular degeneration, an eye disease…
Data presented May 19, 2006 at the Heart Rhythm Society’s 27th Annual Scientific Sessions finds that during a 10-year study period more than one in five automatic external defibrillators (AEDs)…
Scientists at Schepens Eye Research Institute, an affiliate of Harvard Medical School, are the first to discover a switch inside blood vessel cells that controls angiogenesis (new blood vessel growth).…
New research by Dana-Farber Cancer Institute scientists suggests that it may one day be possible to immunize healthy individuals against HIV-1, the virus that causes AIDS. In a study published…
Researchers at Harvard Medical School and Children’s Hospital Boston have isolated a molecule that stimulates the regrowth of damaged adult nerve fibers, providing new hope for those suffering from nerve…
Insulin uses two distinct mechanisms to control glucose and the metabolism of blood fats (lipids) in the liver, a new Joslin Diabetes Center-led study has discovered. Failures in each of…
McLean Hospital researchers, along with colleagues from 11 other study sites nationwide, report that the medication naltrexone and up to 20 sessions of alcohol counseling delivered by a behavioral specialist…
Researchers have found that a vaccine for Alzheimer’s disease improves learning and memory deficits in mice. “Our findings show promise for a potentially safer and more effective Alzheimer’s vaccine in…
Featured series 
